Germany: How are patents interpreted after nullity proceedings?

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Germany: How are patents interpreted after nullity proceedings?

judgment-image-final.jpg

In German patent law, the separation principle applies, according to which a patent claim is interpreted consistently in infringement and opposition, nullity and restriction proceedings. There is no mutual binding effect of decisions of the infringement or nullity courts, instead, each of the courts is responsible for determining the meaning of a patent claim, which is a legal question. For example, the grounds of a nullity decision on the maintenance of a patent with a restricted patent claim may serve as an interpretative aid for the infringement court. In principle, the currently valid version of a patent claim is relevant for its interpretation, and in the case of amendments in opposition or nullity or restriction proceedings, the amended version is therefore relevant. The subject matter of the patent claim is now determined by the wording of the restricted claim, as explained by the description and drawings in light of the grounds of the decision.

In the court decision 15 U 65/17, the Higher Regional Court (OLG) of Düsseldorf discussed a patent claim restricted in nullity proceedings before the Federal Patent Court (BPatG) regarding a urinary catheter set. For this patent, the description was not adapted to the restricted claim. This was of importance as the timing of the production of the low-friction surface character of the urinary catheter was disputed between the parties. According to the invention, a special coating was used in combination with a liquid swelling medium so that the low friction surface was able to glide through the walls of the urethra particularly easily. The claim required that this liquid swelling medium was accommodated in a storage body in a cavity. Due to a foreign reference, it was disputed between the parties whether the production of the low friction surface took place during production outside Germany or only by the user of the urinary catheter set in Germany. Passages of the original description, which was not amended in the nullity proceedings, also applied to embodiments. In these, the manufacturer of the urinary catheter set already achieves these effects.

The Higher Regional Court of Düsseldorf reversed the decision of the lower court. For the interpretation of the disputed feature, according to which the low friction surface character is made prior to use of the catheter, in the absence of an adaptation of the description, the grounds of the nullity decision had to be used as a supplement to the patent description. As a result, the disputed feature as interpreted does not allow the finding of a literal infringement of the patent.

Thomas Ederer

more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article